Congenital Heart Defects Clinical Trial
— MEQCOfficial title:
Outcomes in Patients and Their Closest Relatives Treated for Congenital Heart Disease With Catheter Based or Surgical Techniques.
This study compares clinical, self- reported and cost outcomes in children and adolescents
treated with pulmonary valve implantation, percutaneous versus open surgical technique.
Since cardiac surgery in children and adolescents affect the whole family, the experience of
the patients and their closest relatives are recorded and analysed separately. Cost may be
an important factor in the choice of technology (1). Hence, the present study also aims to
compare savings in costs, percutaneous versus open technique, related to the individual,
their family and society.
1.2 Research questions
1. Percutaneous pulmonary valve implantation or open heart surgery; what are the patients'
and their closest relatives narrative experiences
2. Is there a difference in patient and their closest relatives reported outcomes,
measured as health related quality of life, in patients with congenital pulmonary
disease before the event, 1, 3, 6 and 12 months after percutaneous intervention versus
open heart surgery approach?
3. What is the relationship between patient reported outcomes and clinical outcomes
before, 1, 3, 6 and 12 months after the treatment?
4. Are there savings in costs related to the individual and their family and society
between the two techniques?
Status | Recruiting |
Enrollment | 40 |
Est. completion date | September 2014 |
Est. primary completion date | September 2012 |
Accepts healthy volunteers | No |
Gender | Both |
Age group | 7 Years to 50 Years |
Eligibility |
Inclusion Criteria: - secure indication of pulmonary valve dysfunction (stenosis and, or regurgitation) - an indication of surgical correction - body weight according to the recommendation from the producer of the device - moderate to serious dilatation of right ventricle - considerable leak in the tricuspidal valve - information from former surgery; conduit size, gradient of the stenosis measured by EKKO/MR/ catheterization, X-ray. - be able to speak and communicate well in Norwegian. Exclusion Criteria: - aggressive endocarditis - not circumferential deposit of calcium - < 20 kg - not able to understand, speak or communicate well in Norwegian |
Allocation: Non-Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Health Services Research
Country | Name | City | State |
---|---|---|---|
Norway | The Interventional Centre, Rikshospitalet, Oslo University Hospital | Oslo | Sognsvannsvn 20 |
Lead Sponsor | Collaborator |
---|---|
Oslo University Hospital |
Norway,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Quality of life | Percutaneous pulmonary valve implantation or open heart surgery; what are the patients and their closest relatives narrative experiences. Measured before the event, 1, 3, 6, and 12 month's after treatment. | up to 12 month's after treatment | Yes |
Secondary | Clinical outcomes | What is the relationship between patient reported outcomes and clinical outcomes before, 1, 3, 6 and 12 months after the treatment Is there a difference in the effect of percutaneous versus open surgical technique on operative time, complication rate and reoperations in the peri- and postoperative period? |
up to 12 months after treatment | Yes |
Secondary | Are there savings in costs related to the individual and their family and society between the two techniques? | In order to describe and compare the differences in costs with patients outcomes and quality-adjusted life years, this study aim to calculate both in-hospital care and out-patient clinical costs between percutaneous pulmonary valve implantation and conventional open heart surgery. Measured Before the event, 1, 3, 6 and 12 months after surgery. | up to 12 months after surgery | Yes |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT01671566 -
Interval Training in Adults With Congenital Heart Disease a Randomized Trial
|
N/A | |
Completed |
NCT01567579 -
An Evaluation of Routine Developmental Follow-Up in Infants and Children With Congenital Heart Disease
|
||
Withdrawn |
NCT00981591 -
Inhaled Iloprost as an Adjunct to Inhaled Nitric Oxide in Pediatric Critical Care Patients
|
Phase 1/Phase 2 | |
Terminated |
NCT00208676 -
Using Tissue Doppler/Synchronization to Determine Heart Function in Children With Congenital Heart Disease
|
N/A | |
Completed |
NCT01941576 -
Effects of rhBNP in Pediatrics After Corrective Repair of Tetralogy Of Fallot
|
N/A | |
Completed |
NCT01475357 -
Intestinal Function in Neonates With Complex Congenital Heart Disease
|
N/A | |
Active, not recruiting |
NCT01227096 -
Randomized Controlled Trial of the Effects of Electroacupuncture Preconditioning in Children Undergoing Cardiac Surgery
|
N/A | |
Completed |
NCT01201486 -
Use of Color Doppler in Routine Examination of Fetal Heart in Second Trimester
|
N/A | |
Completed |
NCT00397514 -
Assessing the Hemodynamic Benefits of Cardiac Resynchronization Therapy in Children Following Open-Heart Surgery
|
N/A | |
Completed |
NCT02232399 -
Is Levosimendan Superior to Milrinone Regarding Acute Kidney Injury After Cardiac Surgery for Congenital Heart Disease?
|
Phase 2 | |
Completed |
NCT05191654 -
Investigation of Cardiopulmonary Parameters, Motor Development and Muscle Strength in DS With and Without CHD
|
||
Recruiting |
NCT06267859 -
Development of Methods for Effective Treatment and Improvement of Common Somatic Diseases in Children
|
Early Phase 1 | |
Completed |
NCT02320669 -
Phase 3 Triiodothyronine Supplementation for Infants After Cardiopulmonary Bypass
|
Phase 3 | |
Completed |
NCT01489475 -
Plasma Angiopoietin Levels in Children Following Cardiopulmonary Bypass
|
N/A | |
Withdrawn |
NCT00579358 -
Molecular Basis of Congenital Heart Defects
|
||
Recruiting |
NCT01196182 -
Congenital Heart Disease GEnetic NEtwork Study (CHD GENES)
|
||
Recruiting |
NCT03822442 -
MRI to Predict Rejection and Failure in Transplant and Cardiomyopathy Patients
|
||
Recruiting |
NCT04382573 -
Better Delineation of CDK13 Related Phenotype and Epigenetic Signature.
|
||
Completed |
NCT00450684 -
Cardiac Resynchronization Therapy in Congenital Heart Defects
|
Phase 2/Phase 3 | |
Terminated |
NCT00208754 -
Heart Failure in Adult Patients With a History of Congenital Heart Disease
|
N/A |